Randomised trial of 23-valent pneumococcal capsular polysaccharide vaccine in prevention of pneumonia in middle-aged and elderly people

Lancet

Volumn 351, Issue 9100, 1998, Pages 399-403

  Ortqvist, A ^a   Hedlund, J ^a   Burman, L A ^a   Elbel, E ^a   Hofer, M ^a   Leinonen, M ^a   Lindblad, I ^a   Sundelof, S ^a   Kalin, M ^a   Aufwerber, E ^a   Granstrom, G ^a   Blomqvist, S ^a   Franzen, C ^a   Neringer, R ^a   Makitalo, S ^a  

^a DANDERYD HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

PNEUMOCOCCUS VACCINE; POLYSACCHARIDE VACCINE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; LOBAR PNEUMONIA; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REGRESSION ANALYSIS; SWEDEN;

EID: 0346594413     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(97)07358-3     Document Type: Article

References (30)

1. RV Sims WC Steinmann JH McConville LR King WC Zwick JS Schwartz The clinical effectiveness of pneumococcal vaccine in the elderly Ann Intern Med 108 1988 653 657
2. ED Shapiro AT Berg R Austrian The protective efficacy of polyvalent pneumococcal polysaccharide vaccine N Engl J Med 325 1991 1453 1460
3. JC Butler RF Breiman JF Campbell HB Lipman CV Broome RR Facklam Pneumococcal polysaccharide vaccine efficacy JAMA 270 1993 1826 1831
4. BM Farr BL Johnston DK Cobb Preventing pneumococcal bacteremia in patients at risk Arch Intern Med 155 1995 2336 2340
5. R Austrian RM Douglas G Schiffman Prevention of pneumococcal pneumonia by vaccination Trans Assoc Am Physicians 89 1976 184 194
6. P Smit D Oberholzer S Hayden-Smith HJ Koornhof MR Hilleman Protective efficacy of pneumococcal polysaccharide vaccines JAMA 238 1977 2613 2616
7. MS Simberkoff AP Cross M Al-Ibrahim Efficacy of pneumococcal vaccine in high-risk patients N Engl J Med 315 1986 1318 1327
8. AL Davis CP Aranda G Schiffman LC Christianson Pneumococcal infection and immunologic response to pneumococcal vaccine in chronic obstructive pulmonary disease: a pilot study Chest 92 1987 204 212
9. JA Leech A Gervais FL Ruben Efficacy of pneumococcal vaccine in severe chronic obstructive pulmonary disease Can Med Assoc J 136 1987 361 365
10. DS Fedson ED Shapiro FM LaForce Pneumococcal vaccine after 15 years of use Arch Intern Med 154 1994 2531 2535
11. JD Clemens ED Shapiro Resolving the pneumococcal vaccine controversy: are there alternatives to randomised clinical trials? Rev Infect Dis 6 1984 589 600
12. DS Fedson MP Harward RA Reid DL Kaiser Hospital-based pneumococcal immunization JAMA 264 1990 1117 1122
13. JU Hedlund BÅ Örtqvist ME Kalin G Scalia-Tomba J Giesecke Risk of pneumonia in patients previously treated in hospital for pneumonia Lancet 340 1992 396 397
14. JC Butler RF Breiman JF Campbell HB Lipman CV Broome RR Facklam Pneumococcal polysaccharide vaccine efficacy: an evaluation of current recommendations JAMA 270 1993 1826 1831
15. Å Örtqvist J Hedlund L Grillner Aetiology, outcome and prognostic factors in community-acquired pneumonia requiring hospitalisation Eur Respir J 3 1990 1105 1113
16. JU Hedlund ME Kalin BÅ Örtqvist J Henrichsen Antibody response to pneumococcal vaccine in middle-aged and elderly patients recently treated for pneumonia Arch Intern Med 154 1994 1961 1965
17. M Kalin AA Lindberg G Tunevall Etiological diagnosis of bacterial pneumonia by Gram stain and quantitative culture of expectorates Scand J Infect Dis 15 1983 153 160
18. E Jalonen JC Paton M Koskela Y Kerttula M Leinonen Measurement of antibody responses to Pneumolysin: a promising method for the presumptive etiological diagnosis of pneumococcal pneumonia J Infect 19 1989 127 134
19. M Leinonen H Syrjälä E Jalonen P Kujala F Herva Demonstration of pneumolysin antibodies in circulating immune complexes: a new diagnostic method for pneumococcal pneumonia Serodiagn Immunother Infect Dis 4 1990 451 458
20. MT Kauppinen E Herva P Kujala M Leinonen H Syrjälä The etiology of community-acquired pneumonia among hospitalised patients during a Chlamydia pneumoniae epidemic in Finland J Infect Dis 172 1995 1330 1335
21. DR Cox D Oaks Analysis of survival data 1984 Chapman and Hall London
22. MJ Fine MA Smith CA Carson Efficacy of pneumococcal vaccination in adults: a meta-analysis of randomised controlled trials Arch Intern Med 154 1994 2666 2677
23. C Jokinen L Heiskanen H Juvonen Incidence of community-acquired pneumonia in the population of four municipalities in eastern Finland Am J Epidemiol 137 1993 977 988
24. JF Plouffe RF Breiman RR Facklam Bacteremia with Streptococcus pneumoniae. JAMA 275 1996 194 198
25. J Hedlund SB Svenson M Kalin Incidence, capsular types, and antibiotic susceptibility of invasive Streptococcus pneumoniae in Sweden Clin Infect Dis 21 1995 948 953
26. T Magnus BM Andersen Serotypes and resistance patterns of Streptococcus pneumoniae causing systemic disease in Northern Norway Eur J Clin Microbiol Infect Dis 14 1995 229 234
27. J Gaillat D Zmirou MR Mallaret Essai clinique du vaccin antipneumococcique chez personnes agées vivant en institution Rev Epidemiol Santé Publique 33 1985 437 444
28. JT Macfarlane MJ Ward RG Finch D Macrae Hospital-study of adult community-acquired pneumonia Lancet ii 1982 255 258
29. British Thoracic Society. Community-acquired pneumonia in adults in British hospitals in 1982–83: a survey of aetiology, mortality, prognostic factors and outcome QJM 62 1987 195 220 new series
30. HC Forrester DW Jahnigen FM LaForce Inefficacy of pneumococcal vaccine in a high-risk population Am J Med 83 1987 425 430